Close

Rating History for Sarepta Therapeutics (SRPT) by Oppenheimer

More Stocks Rated by Oppenheimer | Latest Ratings for SRPT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/31/2023 Hartaj Singh Downgrade Perform
(Outperform)		 N/A
(N/A)		 107.65
(115.62)		 7.4% Details